<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">39375351</PMID><DateCompleted><Year>2024</Year><Month>10</Month><Day>07</Day></DateCompleted><DateRevised><Year>2024</Year><Month>10</Month><Day>10</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2041-1723</ISSN><JournalIssue CitedMedium="Internet"><Volume>15</Volume><Issue>1</Issue><PubDate><Year>2024</Year><Month>Oct</Month><Day>07</Day></PubDate></JournalIssue><Title>Nature communications</Title><ISOAbbreviation>Nat Commun</ISOAbbreviation></Journal><ArticleTitle>Inhibition of neutrophil swarming by type I interferon promotes intracellular bacterial evasion.</ArticleTitle><Pagination><StartPage>8663</StartPage><MedlinePgn>8663</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">8663</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1038/s41467-024-53060-4</ELocationID><Abstract><AbstractText>Listeria monocytogenes (LM) possesses the ability to breach multiple barriers and elicit intricate immune responses. However, there remains a lack of explicit understanding regarding how LM evades innate immune surveillance within the body. Here, we utilized liver intravital imaging to elucidate the dynamic process of LM during infection in the liver. We discovered that LM can rapidly escape from Kupffer cells (KCs) through listeriolysin O (LLO) and proliferate within hepatocytes. Upon LM exposure to the hepatic sinusoids, neutrophils rapidly aggregate at the site of infection. Subsequently, LM can induce type I interferon (IFN-I) production primarily in the spleen, which acts systemically on neutrophils to hamper their swarming by deactivating the ERK pathway, thus evading neutrophil-mediated eradication. Furthermore, our findings suggest that virus-induced IFN-I suppresses neutrophil swarming, and COVID-19 patients exhibit impaired neutrophil aggregation function. In conclusion, our findings provide compelling evidence demonstrating that intracellular bacteria represented by LM can hijack host defense mechanisms against viral infections to evade immune surveillance. Additionally, impaired neutrophil swarming caused by IFN-I is one of the significant factors contributing to the increased susceptibility to bacterial infections following viral infections.</AbstractText><CopyrightInformation>© 2024. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Shimin</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Oncology, The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yao</LastName><ForeName>Qi</ForeName><Initials>Q</Initials><AffiliationInfo><Affiliation>Key Laboratory of Immune Response and Immunotherapy, Center for Advanced Interdisciplinary Science and Biomedicine of IHM, School of Basic Medical Sciences, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Jiajia</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Key Laboratory of Immune Response and Immunotherapy, Center for Advanced Interdisciplinary Science and Biomedicine of IHM, School of Basic Medical Sciences, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yang</LastName><ForeName>Haoxiang</ForeName><Initials>H</Initials><Identifier Source="ORCID">0000-0003-0409-3753</Identifier><AffiliationInfo><Affiliation>CAS Key Laboratory of Mechanical Behavior and Design of Materials, Department of Modern Mechanics, CAS Center for Excellence in Complex System Mechanics, University of Science and Technology of China, Hefei, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Qian</LastName><ForeName>Rui</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Clinical Laboratory, First Affiliated Hospital of Anhui Medical University, Hefei, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zheng</LastName><ForeName>Meijuan</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Clinical Laboratory, First Affiliated Hospital of Anhui Medical University, Hefei, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wu</LastName><ForeName>Ning</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>The First Affiliated Hospital of Anhui Medical University and Institute of Clinical Immunology Anhui Medical University, Hefei, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jiang</LastName><ForeName>Hongyuan</ForeName><Initials>H</Initials><Identifier Source="ORCID">0000-0003-0266-3011</Identifier><AffiliationInfo><Affiliation>CAS Key Laboratory of Mechanical Behavior and Design of Materials, Department of Modern Mechanics, CAS Center for Excellence in Complex System Mechanics, University of Science and Technology of China, Hefei, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Lu</ForeName><Initials>L</Initials><Identifier Source="ORCID">0009-0008-4773-5377</Identifier><AffiliationInfo><Affiliation>Department of Oncology, The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, China. lilu@ustc.edu.cn.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zeng</LastName><ForeName>Zhutian</ForeName><Initials>Z</Initials><Identifier Source="ORCID">0000-0002-3213-7664</Identifier><AffiliationInfo><Affiliation>Department of Oncology, The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, China. zengzt@ustc.edu.cn.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Key Laboratory of Immune Response and Immunotherapy, Center for Advanced Interdisciplinary Science and Biomedicine of IHM, School of Basic Medical Sciences, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, China. zengzt@ustc.edu.cn.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>82071773 and 32270958</GrantID><Agency>National Natural Science Foundation of China (National Science Foundation of China)</Agency><Country /></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>10</Month><Day>07</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Nat Commun</MedlineTA><NlmUniqueID>101528555</NlmUniqueID><ISSNLinking>2041-1723</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D001427">Bacterial Toxins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D006360">Heat-Shock Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D006460">Hemolysin Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>R06ZRQ1YX9</RegistryNumber><NameOfSubstance UI="C038705">hlyA protein, Listeria monocytogenes</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D007370">Interferon Type I</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001427" MajorTopicYN="N">Bacterial Toxins</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006360" MajorTopicYN="N">Heat-Shock Proteins</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006460" MajorTopicYN="N">Hemolysin Proteins</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D022781" MajorTopicYN="N">Hepatocytes</DescriptorName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D057131" MajorTopicYN="N">Immune Evasion</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007113" MajorTopicYN="N">Immunity, Innate</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007370" MajorTopicYN="Y">Interferon Type I</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007728" MajorTopicYN="Y">Kupffer Cells</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008089" MajorTopicYN="Y">Listeria monocytogenes</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008088" MajorTopicYN="Y">Listeriosis</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName><QualifierName UI="Q000382" MajorTopicYN="N">microbiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008099" MajorTopicYN="N">Liver</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName><QualifierName UI="Q000382" MajorTopicYN="N">microbiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D020935" MajorTopicYN="N">MAP Kinase Signaling System</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008810" MajorTopicYN="N">Mice, Inbred C57BL</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009504" MajorTopicYN="Y">Neutrophils</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013154" MajorTopicYN="N">Spleen</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading></MeshHeadingList><CoiStatement>The authors have no conflicts of interest to declare.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>11</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>9</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>10</Month><Day>8</Day><Hour>0</Hour><Minute>24</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>10</Month><Day>8</Day><Hour>0</Hour><Minute>23</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>10</Month><Day>7</Day><Hour>23</Hour><Minute>25</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>10</Month><Day>7</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39375351</ArticleId><ArticleId IdType="pmc">PMC11458870</ArticleId><ArticleId IdType="doi">10.1038/s41467-024-53060-4</ArticleId><ArticleId IdType="pii">10.1038/s41467-024-53060-4</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Murray, E. G. D., Webb, R. A. &amp; Swann, M. B. R. A disease of rabbits characterised by a large mononuclear leucocytosis, caused by a hitherto undescribed bacillus Bacterium monocytogenes (n.sp.). J. Pathol. Bacteriol.29, 407–439 (1926).</Citation></Reference><Reference><Citation>Radoshevich, L. &amp; Cossart, P. Listeria monocytogenes: towards a complete picture of its physiology and pathogenesis. Nat. Rev. Microbiol.16, 32–46 (2017).</Citation><ArticleIdList><ArticleId IdType="pubmed">29176582</ArticleId></ArticleIdList></Reference><Reference><Citation>Ebe, Y. et al. The role of Kupffer cells and regulation of neutrophil migration into the liver by macrophage inflammatory protein-2 in primary listeriosis in mice. Pathol. Int.49, 519–532 (1999).</Citation><ArticleIdList><ArticleId IdType="pubmed">10469395</ArticleId></ArticleIdList></Reference><Reference><Citation>Czuczman, M. A. et al. Listeria monocytogenes exploits efferocytosis to promote cell-to-cell spread. Nature509, 230–234 (2014).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4151619</ArticleId><ArticleId IdType="pubmed">24739967</ArticleId></ArticleIdList></Reference><Reference><Citation>Smith, G. A., Portnoy, D. A. &amp; Theriot, J. A. Asymmetric distribution of the Listeria monocytogenes ActA protein is required and sufficient to direct actin-based motility. Mol. Microbiol17, 945–951 (1995).</Citation><ArticleIdList><ArticleId IdType="pubmed">8596443</ArticleId></ArticleIdList></Reference><Reference><Citation>Carr, K. D. et al. Specific depletion reveals a novel role for neutrophil-mediated protection in the liver during Listeria monocytogenes infection. Eur. J. Immunol.41, 2666–2676 (2011).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3517125</ArticleId><ArticleId IdType="pubmed">21660934</ArticleId></ArticleIdList></Reference><Reference><Citation>Nathan, C. Neutrophils and immunity: challenges and opportunities. Nat. Rev. Immunol.6, 173–182 (2006).</Citation><ArticleIdList><ArticleId IdType="pubmed">16498448</ArticleId></ArticleIdList></Reference><Reference><Citation>Lämmermann, T. et al. Neutrophil swarms require LTB4 and integrins at sites of cell death in vivo. Nature498, 371–375 (2013).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3879961</ArticleId><ArticleId IdType="pubmed">23708969</ArticleId></ArticleIdList></Reference><Reference><Citation>Kienle, K. et al. Neutrophils self-limit swarming to contain bacterial growth in vivo. Science372, eabe7729 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8926156</ArticleId><ArticleId IdType="pubmed">34140358</ArticleId></ArticleIdList></Reference><Reference><Citation>Pestka, S., Krause, C. D. &amp; Walter, M. R. Interferons, interferon-like cytokines. Immunol. Rev.202, 8–32 (2004).</Citation><ArticleIdList><ArticleId IdType="pubmed">15546383</ArticleId></ArticleIdList></Reference><Reference><Citation>González-Navajas, J. M., Lee, J., David, M. &amp; Raz, E. Immunomodulatory functions of type I interferons. Nat. Rev. Immunol.12, 125–135 (2012).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3727154</ArticleId><ArticleId IdType="pubmed">22222875</ArticleId></ArticleIdList></Reference><Reference><Citation>Mesev, E. V., LeDesma, R. A. &amp; Ploss, A. Decoding type I and III interferon signalling during viral infection. Nat. Microbiol.4, 914–924 (2019).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6554024</ArticleId><ArticleId IdType="pubmed">30936491</ArticleId></ArticleIdList></Reference><Reference><Citation>Auerbuch, V., Brockstedt, D. G., Meyer-Morse, N., O’Riordan, M. &amp; Portnoy, D. A. Mice lacking the type I interferon receptor are resistant to Listeria monocytogenes. J. Exp. Med.200, 527–533 (2004).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2211930</ArticleId><ArticleId IdType="pubmed">15302899</ArticleId></ArticleIdList></Reference><Reference><Citation>Stanley, S. A., Johndrow, J. E., Manzanillo, P. &amp; Cox, J. S. The type I IFN response to infection with Mycobacterium tuberculosis requires ESX-1-mediated secretion and contributes to pathogenesis. J. Immunol.178, 3143–3152 (2007).</Citation><ArticleIdList><ArticleId IdType="pubmed">17312162</ArticleId></ArticleIdList></Reference><Reference><Citation>Henry, T. et al. Type I IFN signaling constrains IL-17A/F secretion by γδ T cells during bacterial infections. J. Immunol.184, 3755–3767 (2010).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2879132</ArticleId><ArticleId IdType="pubmed">20176744</ArticleId></ArticleIdList></Reference><Reference><Citation>Osborne, S. E. et al. Type I interferon promotes cell-to-cell spread of Listeria monocytogenes. Cell. Microbiol.10.1111/cmi.12660 (2017).</Citation><ArticleIdList><ArticleId IdType="pubmed">27582004</ArticleId></ArticleIdList></Reference><Reference><Citation>Tan, J. M. J. et al. Listeria exploits IFITM3 to suppress antibacterial activity in phagocytes. Nat. Commun.12, 4999 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8371165</ArticleId><ArticleId IdType="pubmed">34404769</ArticleId></ArticleIdList></Reference><Reference><Citation>Rayamajhi, M., Humann, J., Penheiter, K., Andreasen, K. &amp; Lenz, L. L. Induction of IFN-alphabeta enables Listeria monocytogenes to suppress macrophage activation by IFN-gamma. J. Exp. Med.207, 327–337 (2010).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2822610</ArticleId><ArticleId IdType="pubmed">20123961</ArticleId></ArticleIdList></Reference><Reference><Citation>Brzoza-Lewis, K. L., Jason Hoth, J. &amp; Hiltbold, E. M. Type I interferon signaling regulates the composition of inflammatory infiltrates upon infection with Listeria monocytogenes. Cell. Immunol.273, 41–51 (2012).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3264831</ArticleId><ArticleId IdType="pubmed">22212606</ArticleId></ArticleIdList></Reference><Reference><Citation>Jia, T., Leiner, I., Dorothee, G., Brandl, K. &amp; Pamer, E. G. MyD88 and type I interferon receptor-mediated chemokine induction and monocyte recruitment during Listeria monocytogenes infection. J. Immunol.183, 1271–1278 (2009).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2735446</ArticleId><ArticleId IdType="pubmed">19553532</ArticleId></ArticleIdList></Reference><Reference><Citation>McNab, F., Mayer-Barber, K., Sher, A., Wack, A. &amp; O’Garra, A. Type I interferons in infectious disease. Nat. Rev. Immunol.15, 87–103 (2015).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7162685</ArticleId><ArticleId IdType="pubmed">25614319</ArticleId></ArticleIdList></Reference><Reference><Citation>Sheykhsaran, E., Hemmat, N. &amp; Baghi, H. B. Influenza A virus and related secondary bacterial infections. Rev. Med. Microbiol.30, 205–211 (2019).</Citation></Reference><Reference><Citation>Manna, S., Baindara, P. &amp; Mandal, S. M. Molecular pathogenesis of secondary bacterial infection associated to viral infections including SARS-CoV-2. J. Infect. Public Health13, 1397–1404 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7359806</ArticleId><ArticleId IdType="pubmed">32712106</ArticleId></ArticleIdList></Reference><Reference><Citation>Zeng, Z. T. et al. CRIg functions as a macrophage pattern recognition receptor to directly bind and capture blood-borne gram-positive bacteria. Cell Host Microbe20, 99–106 (2016).</Citation><ArticleIdList><ArticleId IdType="pubmed">27345697</ArticleId></ArticleIdList></Reference><Reference><Citation>Blériot, C. et al. Liver-resident macrophage necroptosis orchestrates type 1 microbicidal inflammation and type-2-mediated tissue repair during bacterial infection. Immunity42, 145–158 (2015).</Citation><ArticleIdList><ArticleId IdType="pubmed">25577440</ArticleId></ArticleIdList></Reference><Reference><Citation>Uderhardt, S., Martins, A. J., Tsang, J. S., Lämmermann, T. &amp; Germain, R. N. Resident macrophages cloak tissue microlesions to prevent neutrophil-driven inflammatory damage. Cell177, 541–555.e517 (2019).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6474841</ArticleId><ArticleId IdType="pubmed">30955887</ArticleId></ArticleIdList></Reference><Reference><Citation>Dahlgren, C., Karlsson, A. &amp; Bylund, J. Intracellular neutrophil oxidants: from laboratory curiosity to clinical reality. J. Immunol.202, 3127–3134 (2019).</Citation><ArticleIdList><ArticleId IdType="pubmed">31109945</ArticleId></ArticleIdList></Reference><Reference><Citation>Laleu, B. et al. First in class, potent, and orally bioavailable NADPH oxidase isoform 4 (Nox4) inhibitors for the treatment of idiopathic pulmonary fibrosis. J. Med. Chem.53, 7715–7730 (2010).</Citation><ArticleIdList><ArticleId IdType="pubmed">20942471</ArticleId></ArticleIdList></Reference><Reference><Citation>Castanheira, F. V. S. &amp; Kubes, P. Neutrophils and NETs in modulating acute and chronic inflammation. Blood133, 2178–2185 (2019).</Citation><ArticleIdList><ArticleId IdType="pubmed">30898862</ArticleId></ArticleIdList></Reference><Reference><Citation>Li, P. et al. PAD4 is essential for antibacterial innate immunity mediated by neutrophil extracellular traps. J. Exp. Med.207, 1853–1862 (2010).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2931169</ArticleId><ArticleId IdType="pubmed">20733033</ArticleId></ArticleIdList></Reference><Reference><Citation>N, E. S. W. C. H. A. S. I. R. I. S. Enhanced resistance to Listeria monocytogenes in splenectomized mice. Immunology33, 851 (1977).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1445541</ArticleId><ArticleId IdType="pubmed">412778</ArticleId></ArticleIdList></Reference><Reference><Citation>Skamene, E., Chayasirisobhon, W. &amp; Konshavn, P. A. L. Increased phagocytic activity of splenectomized mice challenged with Listeria monocytogenes. Immunology34, 901–907 (1978).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1457212</ArticleId><ArticleId IdType="pubmed">96011</ArticleId></ArticleIdList></Reference><Reference><Citation>Serbina, N. V., Shi, C. &amp; Pamer, E. G. in Advances in Immunology, Vol. 113 (eds Emil, R. U. &amp; Javier, A. C.) 119–134 (Academic Press, 2012).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3985089</ArticleId><ArticleId IdType="pubmed">22244581</ArticleId></ArticleIdList></Reference><Reference><Citation>Chakravortty, D. et al. Production of IFN-β during Listeria monocytogenes infection is restricted to monocyte/macrophage lineage. PLoS One6, e18543 (2011).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3073975</ArticleId><ArticleId IdType="pubmed">21494554</ArticleId></ArticleIdList></Reference><Reference><Citation>WOOD, P. R., Young, A. M., McKIMM-BRESCHKIN, J. L. &amp; CHEERS, C. Effect of splenectomy on production of interferon and colonystimulating factor in Listeria monocytogenes-infected mice. Infect. Immun.46, 860–861 (1984).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC261628</ArticleId><ArticleId IdType="pubmed">6209225</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang, G. F., Budker, V. &amp; Wolff, J. A. High levels of foreign gene expression in hepatocytes after tail vein injections of naked plasmid DNA. Hum. Gene Ther.10, 1735–1737 (1999).</Citation><ArticleIdList><ArticleId IdType="pubmed">10428218</ArticleId></ArticleIdList></Reference><Reference><Citation>Hu, N. et al. A novel positive feedback loop involving FASN/p-ERK1/2/5-LOX/LTB4/FASN sustains high growth of breast cancer cells. Acta Pharmacol. Sin.32, 921–929 (2011).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4003129</ArticleId><ArticleId IdType="pubmed">21643005</ArticleId></ArticleIdList></Reference><Reference><Citation>Romerio, F., A. R. a. D. Z. Interferon-α2b reduces phosphorylation and activity of MEK and ERK through a Ras/Raf-independent mechanism. Br. J. Cancer83, 532–538 (2000).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2374650</ArticleId><ArticleId IdType="pubmed">10945503</ArticleId></ArticleIdList></Reference><Reference><Citation>Platanias, L. C. Mechanisms of type-I- and type-II-interferon-mediated signalling. Nat. Rev. Immunol.5, 375–386 (2005).</Citation><ArticleIdList><ArticleId IdType="pubmed">15864272</ArticleId></ArticleIdList></Reference><Reference><Citation>Song, Z., Bhattacharya, S., Clemens, R. A. &amp; Dinauer, M. C. Molecular regulation of neutrophil swarming in health and disease: lessons from the phagocyte oxidase. iScience26, 108034 (2023).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10579437</ArticleId><ArticleId IdType="pubmed">37854699</ArticleId></ArticleIdList></Reference><Reference><Citation>Jamieson, A. M., Yu, S., Annicelli, C. H. &amp; Medzhitov, R. Influenza virus-induced glucocorticoids compromise innate host defense against a secondary bacterial infection. Cell Host Microbe7, 103–114 (2010).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2836270</ArticleId><ArticleId IdType="pubmed">20159617</ArticleId></ArticleIdList></Reference><Reference><Citation>Manda-Handzlik, A. et al. The influence of agents differentiating HL-60 cells toward granulocyte-like cells on their ability to release neutrophil extracellular traps. Immunol. Cell Biol.96, 413–425 (2018).</Citation><ArticleIdList><ArticleId IdType="pubmed">29380901</ArticleId></ArticleIdList></Reference><Reference><Citation>Langford, B. J. et al. Antimicrobial resistance in patients with COVID-19: a systematic review and meta-analysis. Lancet Microbe4, e179–e191 (2023).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9889096</ArticleId><ArticleId IdType="pubmed">36736332</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang, L. et al. Dynamic blood single-cell immune responses in patients with COVID-19. Signal Transduct. Target Ther.6, 110 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7936231</ArticleId><ArticleId IdType="pubmed">33677468</ArticleId></ArticleIdList></Reference><Reference><Citation>Maudet, C. et al. Bacterial inhibition of Fas-mediated killing promotes neuroinvasion and persistence. Nature603, 900–906 (2022).</Citation><ArticleIdList><ArticleId IdType="pubmed">35296858</ArticleId></ArticleIdList></Reference><Reference><Citation>Shi, C. et al. Ly6G+ neutrophils are dispensable for defense against systemic Listeria monocytogenes infection. J. Immunol.187, 5293–5298 (2011).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3208088</ArticleId><ArticleId IdType="pubmed">21976773</ArticleId></ArticleIdList></Reference><Reference><Citation>Ley, K. et al. Neutrophils new insights and open questions. Sci. Immunol.3, eaat4579 (2018).</Citation><ArticleIdList><ArticleId IdType="pubmed">30530726</ArticleId></ArticleIdList></Reference><Reference><Citation>Xin, L. et al. Type I IFN receptor regulates neutrophil functions and innate immunity to Leishmania parasites. J. Immunol.184, 7047–7056 (2010).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4159077</ArticleId><ArticleId IdType="pubmed">20483775</ArticleId></ArticleIdList></Reference><Reference><Citation>Stock, A. T., Smith, J. M. &amp; Carbone, F. R. Type I IFN suppresses Cxcr2 driven neutrophil recruitment into the sensory ganglia during viral infection. J. Exp. Med.211, 751–759 (2014).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4010892</ArticleId><ArticleId IdType="pubmed">24752295</ArticleId></ArticleIdList></Reference><Reference><Citation>Lebratti, T. et al. A sustained type I IFN-neutrophil-IL-18 axis drives pathology during mucosal viral infection. eLife10, e65762 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8163503</ArticleId><ArticleId IdType="pubmed">34047696</ArticleId></ArticleIdList></Reference><Reference><Citation>Boxx, G. M. &amp; Cheng, G. The roles of type I interferon in bacterial infection. Cell Host Microbe19, 760–769 (2016).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5847370</ArticleId><ArticleId IdType="pubmed">27281568</ArticleId></ArticleIdList></Reference><Reference><Citation>Ali, S. et al. Sources of type I interferons in infectious immunity: plasmacytoid dendritic cells not always in the driver’s seat. Front. Immunol.10, 778 (2019).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6473462</ArticleId><ArticleId IdType="pubmed">31031767</ArticleId></ArticleIdList></Reference><Reference><Citation>Aoshi, T. et al. The cellular niche of Listeria monocytogenes infection changes rapidly in the spleen. Eur. J. Immunol.39, 417–425 (2009).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2749683</ArticleId><ArticleId IdType="pubmed">19130474</ArticleId></ArticleIdList></Reference><Reference><Citation>Jenne, Craig N. et al. Neutrophils recruited to sites of infection protect from virus challenge by releasing neutrophil extracellular traps. Cell Host Microbe13, 169–180 (2013).</Citation><ArticleIdList><ArticleId IdType="pubmed">23414757</ArticleId></ArticleIdList></Reference><Reference><Citation>Bai, F. et al. A paradoxical role for neutrophils in the pathogenesis of west Nile virus. J. Infect. Dis.202, 1804–1812 (2010).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3053000</ArticleId><ArticleId IdType="pubmed">21050124</ArticleId></ArticleIdList></Reference><Reference><Citation>Hawn, T. R., Wiens, K. E. &amp; Ernst, J. D. The mechanism for type I interferon induction by Mycobacterium tuberculosis is bacterial strain-dependent. PLoS Pathog.12, e1005809 (2016).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4976988</ArticleId><ArticleId IdType="pubmed">27500737</ArticleId></ArticleIdList></Reference><Reference><Citation>Redford, P. S. et al. Influenza A virus impairs control of Mycobacterium tuberculosis coinfection through a type I interferon receptor–dependent pathway. J. Infect. Dis.209, 270–274 (2014).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3873785</ArticleId><ArticleId IdType="pubmed">23935205</ArticleId></ArticleIdList></Reference><Reference><Citation>Cillóniz, C. et al. Bacterial co-infection with H1N1 infection in patients admitted with community acquired pneumonia. J. Infect.65, 223–230 (2012).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7132402</ArticleId><ArticleId IdType="pubmed">22543245</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu, Y. et al. Outcomes of respiratory viral-bacterial co-infection in adult hospitalized patients. eClinicalMedicine. 10.1016/j.eclinm.2021.100955 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8343259</ArticleId><ArticleId IdType="pubmed">34386745</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu, W. et al. In situ expansion and reprogramming of Kupffer cells elicit potent tumoricidal immunity against liver metastasis. J. Clin. Investig.133, e157937 (2023).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10104906</ArticleId><ArticleId IdType="pubmed">36821387</ArticleId></ArticleIdList></Reference><Reference><Citation>Zeng, Z. et al. Sex-hormone-driven innate antibodies protect females and infants against EPEC infection. Nat. Immunol.19, 1100–1111 (2018).</Citation><ArticleIdList><ArticleId IdType="pubmed">30250184</ArticleId></ArticleIdList></Reference><Reference><Citation>Ubags, N. D. J. &amp; Suratt, B. T. in Lung Innate Immunity and Inflammation Methods in Molecular Biology, Ch. 4, 45–57 (Springer, 2018).</Citation></Reference><Reference><Citation>ANDERSEN, D. Ea. B. R. SINGLE-STEP SEPARATION OF RED BLOOD CELLS. J. Immunol. Methods5, 249–252 (1974).</Citation><ArticleIdList><ArticleId IdType="pubmed">4427075</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>